The Ozempic Effect: 10 A-List Celebrities Who Confirmed Using The Weight-Loss Drug And Their Full Biographies
The conversation around Hollywood's dramatic weight loss transformations has reached a fever pitch in late 2025, with the drug Ozempic (semaglutide) becoming the most discussed, and often most controversial, beauty secret on the red carpet. Initially approved for managing Type 2 Diabetes, this injectable medication has fundamentally changed the landscape of celebrity body image, sparking intense public curiosity and ethical debates about access and the pressure of Hollywood beauty standards.
The "Ozempic Effect" is undeniable, influencing everything from fashion trends—dubbed "Ozempic Chic" at the 2025 Oscars—to the very definition of a celebrity's "health journey." As of December 2025, a growing number of A-list stars have moved past the rumors to publicly address their use of the GLP-1 agonist drugs, offering a rare glimpse into the high-stakes world of celebrity weight management and the powerful role pharmaceuticals now play in achieving the coveted Hollywood physique.
Confirmed Celebrity Users and Their Profiles
While speculation runs rampant in the media, only a handful of high-profile figures have definitively confirmed their use of Ozempic or its sister drug, Wegovy, which both contain the active ingredient semaglutide. Here are the full profiles of the most prominent celebrities who have admitted to using the drug, detailing their background and statements.
Oprah Winfrey
- Full Name: Oprah Gail Winfrey
- Date of Birth: January 29, 1954
- Occupation: Talk show host, television producer, actress, author, and philanthropist.
- Career Highlights: Host of The Oprah Winfrey Show (1986–2011); founder of Harpo Productions and the OWN network.
- Ozempic Statement: Oprah confirmed in late 2024 that she was using a weight-loss medication, which she later clarified was a GLP-1 drug. She described the shift as moving away from the shame of dieting and embracing a "medically managed" approach. Her admission was a watershed moment, legitimizing the drug's use in the public eye.
Sharon Osbourne
- Full Name: Sharon Rachel Osbourne (née Levy)
- Date of Birth: October 9, 1952
- Occupation: Television personality, music manager, and author.
- Career Highlights: Co-host of The Talk; judge on The X Factor and America's Got Talent; star of The Osbournes reality show.
- Ozempic Statement: Osbourne has been very open about her significant weight loss, attributing it to Ozempic, which she started taking in 2023. She has since warned about the drug, stating that she struggled with severe side effects, including constant nausea, and that she became "too skinny" and found it difficult to stop the weight loss process.
Amy Schumer
- Full Name: Amy Beth Schumer
- Date of Birth: June 1, 1981
- Occupation: Stand-up comedian, actress, and writer.
- Career Highlights: Creator and star of the sketch comedy series Inside Amy Schumer; star of the film Trainwreck.
- Ozempic Statement: Schumer admitted to trying Ozempic but stopped due to the severe side effects, stating it made her feel "miserable" and "so sick." She has been critical of the Hollywood trend, noting the pressure it puts on women and the potential for misuse.
Rebel Wilson
- Full Name: Rebel Melanie Elizabeth Wilson
- Date of Birth: March 2, 1980
- Occupation: Actress, comedian, writer, and producer.
- Career Highlights: Known for her roles in Pitch Perfect and Bridesmaids.
- Ozempic Statement: Wilson admitted to using Ozempic for a period, particularly during her "Year of Health" journey. She described it as a tool to help manage her appetite, especially for sweets, and acknowledged that the drug can be beneficial for people who struggle with "bottomless appetite."
Other celebrities who have spoken about using GLP-1 drugs include Tracy Morgan, Heather Gay (from The Real Housewives of Salt Lake City), and Charles Barkley, who all confirmed their weight loss was due to the medication.
The 'Ozempic Chic' Phenomenon and Hollywood’s Shifting Standards
The dramatic physical transformations seen across Hollywood in 2024 and 2025 have been collectively termed the "Ozempic Chic" phenomenon. This trend was particularly noticeable at major awards ceremonies, where many stars appeared visibly slimmer, sparking intense media scrutiny and public discussion about the new beauty standard.
The rise of semaglutide has unfortunately coincided with a resurgence of pressure on celebrities to maintain an extremely slender figure, reminiscent of past 'heroin chic' eras. This shift is problematic because it pushes an unrealistic and potentially unhealthy ideal, often achieved through powerful prescription drugs rather than traditional diet and exercise.
The conversation is not just about weight loss; it’s about the ethics of using a drug intended for chronic disease management for purely cosmetic reasons. Public figures like Jameela Jamil and Kate Winslet have been vocal critics of the trend, highlighting the potential for eating disorders and the negative impact on body image for the general public, especially young women.
The Ethical Debate: Drug Shortages and Access
A significant controversy swirling around the Hollywood usage is the resulting drug shortage. As demand for Ozempic and Wegovy surged for cosmetic weight loss, people with Type 2 Diabetes—the drug's intended patient population—reported difficulties in filling their prescriptions. This shortage has fueled a heated ethical debate, with critics arguing that the vanity-driven demand from wealthy celebrities is diverting essential medication from those who need it for life-saving health management.
The pharmaceutical industry has responded by ramping up production of semaglutide and its close competitor, tirzepatide (brand names Mounjaro and Zepbound), but the ethical implications of the "Hollywood trend" continue to dominate the discussion across health and celebrity news outlets.
Understanding Semaglutide: The Science Behind the 'Magic Shot'
To understand the phenomenon, one must understand the science. Ozempic and Wegovy are brand names for semaglutide, a type of medication known as a GLP-1 receptor agonist. This class of drug mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1).
How GLP-1 Agonists Work
- Blood Sugar Control: The primary function is to stimulate insulin release and inhibit glucagon release, which lowers blood sugar levels in people with Type 2 Diabetes.
- Appetite Suppression: GLP-1 also acts on the brain to increase feelings of fullness and reduce appetite. This is the mechanism responsible for the dramatic weight loss.
- Gastric Emptying: The drug slows down the rate at which the stomach empties (gastric emptying), making a person feel full for much longer after eating.
While the weight loss results can be profound—with some users losing over 15% of their body weight—the drug is not without its risks and side effects.
Common and Notorious Side Effects
Celebrities who have spoken about their experience often mention the unpleasant side effects of the medication. These include:
- Gastrointestinal Issues: Severe nausea, vomiting, diarrhea, and constipation are the most common complaints.
- Ozempic Face: A term coined to describe the facial volume loss that occurs with rapid weight loss, leading to a gaunt, aged, or hollowed-out appearance.
- Muscle Loss: Unlike traditional weight loss, GLP-1 drugs can lead to a higher proportion of muscle mass loss, which is detrimental to long-term health and metabolism.
The long-term effects of using these drugs purely for cosmetic weight loss are still being studied, adding another layer of caution to the current Hollywood craze. Stars like Khloe Kardashian and Kyle Richards, who have been rumored to use the drug but deny it, often face intense questioning, reflecting the public's deep skepticism about any rapid transformation that is not attributed to semaglutide.
Conclusion: The Future of Weight Management in the Spotlight
The celebrity embrace of Ozempic has fundamentally altered the public discourse on weight loss, transforming it from a matter of willpower and lifestyle to one of medical intervention. As of late 2025, the trend shows no sign of slowing down, with more stars likely to step forward with their own "medically managed" health journeys. The debate will continue to center on the balance between personal choice and public health responsibility. While these drugs offer a powerful tool for weight management, the high-profile usage by the A-list serves as a constant reminder of the intense, often unsustainable, pressures of maintaining a celebrity image in the modern era.
Detail Author:
- Name : Tyshawn Block III
- Username : wcrona
- Email : alycia77@hickle.com
- Birthdate : 1978-08-03
- Address : 6572 Reilly Knoll Schusterberg, IN 95667-3357
- Phone : +1 (574) 478-2331
- Company : West, McGlynn and Buckridge
- Job : Health Services Manager
- Bio : Est laudantium voluptatem culpa dolores distinctio. Dolores similique non sed qui aut a voluptate. Et rerum eum incidunt est occaecati dolorem. Eos ab rerum et explicabo provident sapiente aut.
Socials
twitter:
- url : https://twitter.com/gunner.mayert
- username : gunner.mayert
- bio : Assumenda non deleniti et. Unde sed et consectetur suscipit odio aut voluptatem eos.
- followers : 1291
- following : 255
facebook:
- url : https://facebook.com/gunnermayert
- username : gunnermayert
- bio : Beatae aut molestias eos impedit. Aut ullam repudiandae numquam nihil.
- followers : 3871
- following : 353
